Chill Brands GroupLSE:CHLL EBIT per Share is £-0.02 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 810 Drug Manufacturers companies, Chill Brands Group ranks better than 77.9% on this metric.
Chill Brands Group's EBIT per Share for the
six
months ended in Mar. 2026 was £-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was £-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 29.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -5.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Chill Brands Group's EBIT per Share or its related term are showing as below:
LSE:CHLL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -69.9 Med: 22.5 Max: 63.3
Current: 29.2
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Chill Brands Group was 63.30% per year. The lowest was -69.90% per year. And the median was 22.50% per year.
LSE:CHLL's 3-Year EBIT Growth Rate is ranked better than 77.9% of 810
companies
in the Drug Manufacturers industry
Industry Median: 7.55
vs LSE:CHLL: 29.20
Chill Brands Group (LSE:CHLL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Chill Brands Group EBIT per Share Related Terms
Chill Brands Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for Chill Brands Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chill Brands Group (LSE:CHLL) has a EBIT per Share of £-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Chill Brands Group and its competitors. According to the industry distribution chart, Chill Brands Group ranks #179 out of 810 companies in the Drug Manufacturers industry, placing it in the top 22.1%.
Is Chill Brands Group's EBIT per Share too high?
Chill Brands Group's current EBIT per Share is £-0.02. Based on the distribution chart, Chill Brands Group ranks #179 out of 810 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Chill Brands Group's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chill Brands Group ranks #179 out of 810 companies for EBIT per Share. This places Chill Brands Group in the top 22% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 7.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.55, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Chill Brands Group and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chill Brands Group's current EBIT per Share is £-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chill Brands Group stock overvalued right now?
Chill Brands Group (LSE:CHLL) has a current EBIT per Share of £-0.02. The current EBIT per Share is £-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Chill Brands Group (LSE:CHLL), the current EBIT per Share is £-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chill Brands Group PLC is a distribution-led consumer packaged goods company mainly serving the UK convenience retail sector. Through its chill connect platform, the company provides direct-to-store distribution and advisory services to brands seeking to expand their distribution into the independent convenience channel. Its product range spans vaping and nicotine alternatives, with active expansion into sundries, beverages, confectionery, and other fast-moving consumer goods. The company also owns the chill.com domain name, which operates as a marketplace for wellness and other consumer products. Geographically, it operates in the United Kingdom (its key revenue-generating market) and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CHLL has been successfully added to your 